Viewing nowCombinationTelonstar Tablet 80/5 milligrams
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
KMS Pharmaceutical Co., Ltd.

MFDS item code 201605757 · Approved 2016.09.30 · Insurance code 654701760
Treatment of essential hypertension not controlled with monotherapy
This medication can be used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine. This helps reduce cardiovascular risks associated with hypertension and improves the patient's health status.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In older adults aged 75 years or above, amlodipine clearance is reduced; therefore, treatment should be started at a lower dose and the dose increased gradually.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose a serious risk to the fetus, especially during the second and third trimesters of pregnancy, so it should not be used by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as severe liver impairment, heart valve disease, severe hypotension, heart failure, or unstable conditions after acute myocardial infarction. When administering this medication, special care should be taken for certain patient groups, including those with primary aldosteronism, liver impairment, gastrointestinal disorders, renovascular hypertension, renal failure, and the elderly. This medication may cause various side effects, including dizziness, peripheral edema, and hypotension; if any unusual symptoms occur, immediate consultation with a healthcare professional is necessary. Symptoms of hypotension may appear if blood pressure drops too low; therefore, patients with insufficient fluids or salts should manage their condition before administration and seek appropriate measures if hypotension occurs. Potassium levels in the blood may increase, so patients at risk for hyperkalemia should have their potassium levels checked regularly through blood tests. As this medication may affect kidney function, patients with impaired renal function need periodic renal function testing. This medication may interact when used in combination with other antihypertensive agents, so patients should inform their healthcare provider if they are taking other medications. It is advisable not to administer this medication to breastfeeding women, and caution should be exercised when driving or operating machinery due to possible dizziness or drowsiness. In case of overdose, severe hypotension, dizziness, and abnormal heart rate may occur, so it is crucial to adhere strictly to the prescribed dosage and contact a healthcare professional immediately if unusual symptoms arise. The safety and efficacy of this medication have not been sufficiently established for children, so its use is not recommended.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1°C and 30°C, away from extreme heat or cold.
Biconvex oval double-layer tablet in white and light blue color
30 tablets (10 tablets/PTP*3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
KMS Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.